Abstract:As hypocretin can markedly affect neurophysiological and behavioural processes in mood disorders. However, few studies have measured changes in hypocretin levels in patients with mood disorders. We estimated the hypocretin-1 plasma levels in mood disorder patients and controls (CON) using an enzyme-linked immunosorbent assay. Results: (i) The hypocretin-1 plasma level was significantly higher in major depressive disorder (MDD) patients [59.04 (35.78–80.12) pg/ml, P < 0.001] and bipolar disorder (BD) patients [65.50 (58.46–74.57) pg/ml, P < 0.001] patients than in CON [49.25 (28.51–80.40) pg/ml]. Moreover, the plasma hypocretin-1 levels in the BD group were significantly higher than those in the MDD group (P < 0.001). (ii). In the MDD group, patients with higher suicidal ideation had higher hypocretin-1 levels [62.09 (38.23–80.12) pg/ml] than those with lower suicidal ideation [59.63 (35.79–77.37) pg/ml), P = 0.032]. (iii). Plasma hypocretin-1 levels were increased in both female and male mood disorder patients compared to CON [male: MDD 60.51 (35.79–80.12) pg/ml; BD 65.40 (58.76–74.14) pg/ml; CON 45.63 (28.51–62.05) pg/ml; all P < 0.016; female: MDD 57.37 (34.59–80.40) pg/ml; BD 65.61 (58.46–74.57) pg/ml; CON 52.92 (38.23–78.89) pg/ml; all P < 0.015]. (iv). In CON, we found a significant negative correlation between plasma hypocretin-1 levels and age (rho = −0.251, P = 0.032), while this negative correlation was absent in the MDD and BD groups. Limitations may partly arise from the relatively small sample size and the medication history of patients participating in our research. We concluded that the clear changes found in plasma hypocretin-1 levels might be applied in the diagnosis of depression and the differential diagnosis of MDD and BD. The clear suicidal-ideation-related change found in hypocretin-1 levels in depression might be taken into account in the prevention of suicidal behaviour and further study of hypocretin-targeted therapies.

Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain

Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Changes in Plasma NPY, IL-1β and Hypocretin in People Who Died by Suicide

Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression.

Correlation of Orexin-A and Brain-Derived Neurotrophic Factor Levels in Metabolic Syndrome and Cognitive Impairment in Schizophrenia Treated with Clozapine

Different Oxytocin and Corticotropin-Releasing Hormone System Changes in Bipolar Disorder and Major Depressive Disorder Patients

Epigenetic Clock Analysis of Blood Samples in Drug-Naive First-Episode Schizophrenia Patients.

Increased Glutamic Acid Decarboxylase Expression in the Hypothalamic Suprachiasmatic Nucleus in Depression

Distinguishing Hypochondriasis and Schizophrenia Using Regional Homogeneity: a Resting-State Fmri Study and Support Vector Machine Analysis.

Increased Hypocretin (orexin) Plasma Level in Depression, Bipolar Disorder Patients.

Alterations of serum neuropeptide levels and their relationship to cognitive impairment and psychopathology in male patients with chronic schizophrenia

Impaired Hypocretin/orexin System Alters Responses to Salient Stimuli in Obese Male Mice.

Peripheral Oxytocin and Vasopressin Modulates Regional Brain Activity Differently in Men and Women with Schizophrenia

A direct estrogenic involvement in the expression of human hypocretin

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

Microstructural Alterations of the Hypothalamus in Parkinson's Disease and Probable REM Sleep Behavior Disorder

Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome

Progressive alterations of resting-state hypothalamic dysconnectivity in schizophrenia

Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia

Hypocretin-1/Hypocretin Receptor 1 Regulates Neuroplasticity and Cognitive Function through Hippocampal Lactate Homeostasis in Depressed Model